| 000 | 02350nam a2200277Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625162449.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-20489 | ||
| 245 | 1 | 0 | _aNutraceuticals and network pharmacology approach for acute kidney injury: A review from the drug discovery aspect |
| 490 | 0 | _vFitoterapia, 168, p.105563, 2023 | |
| 520 | 3 | _aAcute kidney injury (AKI)has become a global health issue, with ?12 million reports yearly, resulting in a persistent increase in morbidity and mortality rates. AKI pathophysiology is multifactorial involving oxidative stress, mitochondrial dysfunction, epigenetic modifications, inflammation, and eventually, cell death. Hence, therapies able to target multiple pathomechanisms can aid in AKI management. To change the drug discovery framework from "one drug, one target" to "multicomponent, multitarget," network pharmacology is evolving as a next-generation research approach. Researchers have used the network pharmacology approach to predict the role of nutraceuticals against different ailments including AKI. Nutraceuticals (herbal products, isolated nutrients, and dietary supplements)belong to the pioneering category of natural products and have shown protective action against AKI. Nutraceuticals have recently drawn attention because of their ability to provide physiological benefits with less toxic effects. This review emphasizes the nutraceuticals that exhibited renoprotection against AKI and can be used either as monotherapy or adjuvant with conventional therapies to boost their effectiveness and lessen the adverse effects. Additionally, the study sheds light on the application of network pharmacology as a cost-effective and time-saving approach for the therapeutic target prediction of nutraceuticals against AKI. | |
| 650 | 1 | 4 | _aACUTE KIDNEY INJURY |
| 650 | 1 | 4 | _aCHRONIC KIDNEY DISEASE |
| 650 | 1 | 4 | _aDRUG DISCOVERY |
| 650 | 1 | 4 | _aNETWORK PHARMACOLOGY |
| 650 | 1 | 4 | _aNUTRACEUTICALS |
| 650 | 1 | 4 | _aPOLYPHARMACOLOGY |
| 700 | 1 | 2 | _aDagar, N. |
| 700 | 1 | 2 | _aKale, A. |
| 700 | 1 | 2 | _aJadhav, H. R. |
| 700 | 1 | 2 | _aGaikwad, A. B. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1wdnYfw7AVXSvTIW3NnOxXiKDGSb4o7yR/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c54580 _d54580 |
||